BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 30, 2017
View Archived Issues
FDA clears Recardio's IND for development of dutogliptin for acute myocardial infarction
Read More
Compugen selects COM-902 as immuno-oncology antibody candidate
Read More
Oncology Venture in-licenses 2-BBB's 2B3-101 for 2X Oncology's pipeline
Read More
Targapremir-210 is a small molecule inhibitor of miR-210 that reprograms oncogenic hypoxic circuit
Read More
S3F-CL-MMAE as a novel anti-STn ADC with promising antitumor activity in vivo
Read More
FDA allows IND for clinical trials of Oratopo
Read More
New ghrelin receptor agonist AZ-4558 shows reduced mechanism-related side effects
Read More
European orphan drug designation for Epidiolex for Lennox-Gastaut syndrome
Read More
Novel SARDs UT-69 and UT-155 show proof-of concept and efficacy in a prostate cancer xenograft model
Read More
EMA grants orphan drug designation to inebilizumab for neuromyelitis optica spectrum disorder
Read More
Jazz licenses Japanese rights for Defitelio and Vyxeos to Nippon Shinyaku
Read More
VL#FIA3-30 demonstrates efficacy in the treatment of erectile dysfunction
Read More
Vertex plans regulatory filings following phase III results for tezacaftor/ivacaftor
Read More
Avillion and Merck KGaA sign codevelopment agreement for IL-17 A/F Nanobody in plaque psoriasis
Read More
FDA grants priority review to BLA filing for CTL-019 for relapsed or refractory B-cell ALL
Read More
Interim data from phase Ib study of DPX-Survivac with epacadostat in ovarian cancer
Read More
Altimmune receives contract modification from BARDA to fund manufacturing of NasoShield
Read More
First patient dosed in phase I trial of JHL-1101 in rheumatoid arthritis
Read More
Hanmi Pharmaceutical and Innovent Biologics establish immuno-oncology partnership
Read More
VenatoRx Pharmaceuticals presents novel beta-lactamase inhibitors
Read More
Selvita announces global license agreement with Menarini for SEL-24
Read More
Glenmark reports phase III results for GSP-301 in seasonal allergic rhinitis
Read More
GlaxoSmithKline Intellectual Property identifies PERK inhibitors
Read More
Qiagen launches ipsogen JAK2 assay for polycythemia vera
Read More
FDA grants priority review to Blincyto sBLA
Read More
Shanghai Jingxin Biomedical and partners patent dopamine D2 and 5-HT1A receptor ligands
Read More
Warp Drive Bio collaborates with GSK to discover new therapeutics
Read More
ViiV Healthcare divulges benzoazepine derivatives
Read More
Redx Pharma discovers antibacterial compounds
Read More